(Total Views: 393)
Posted On: 02/28/2021 8:32:24 PM
Post# of 22465
Re: Puravida19 #18242
From the Innova Medical Group Case Study on the Pasaca website...
“As COVID-19 grows into an endemic, Innova continues to innovate with its rapid antigen test. The company is working on the next generation of Innova rapid antigen test with higher sensitivity and an anti-counterfeiting feature, while still keeping its products affordable.”
So the anti-counterfeiting is ready for the Innova tests.
“As COVID-19 grows into an endemic, Innova continues to innovate with its rapid antigen test. The company is working on the next generation of Innova rapid antigen test with higher sensitivity and an anti-counterfeiting feature, while still keeping its products affordable.”
So the anti-counterfeiting is ready for the Innova tests.
(0)
(0)
